Sangamo Therapeutics (SGMO) Other Gross PP&E Adjustments (2016 - 2025)
Sangamo Therapeutics (SGMO) has 15 years of Other Gross PP&E Adjustments data on record, last reported at -$14.4 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 18.79% year-over-year to -$14.4 million; the TTM value through Sep 2025 reached -$14.4 million, up 18.79%, while the annual FY2024 figure was $36.8 million, 26.94% down from the prior year.
- Other Gross PP&E Adjustments reached -$14.4 million in Q3 2025 per SGMO's latest filing, up from -$15.1 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $50.4 million in Q4 2023 and bottomed at -$70.9 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$27.1 million, with a median of -$20.9 million recorded in 2024.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 1115.53% in 2022, then fell 26.94% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.5 million in 2021, then skyrocketed by 1115.53% to $30.4 million in 2022, then surged by 66.07% to $50.4 million in 2023, then dropped by 26.94% to $36.8 million in 2024, then crashed by 139.17% to -$14.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$14.4 million in Q3 2025, -$15.1 million in Q2 2025, and -$16.0 million in Q1 2025.